Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:981 (3 May), doi:10.1136/bmj.39567.422905.DB
Owen Dyer
1 London
| The first 150 words of the full text of this article appear below. |
The fast growing practice of collecting blood from the umbilical cords of newborn infants is to be regulated for the first time in the United Kingdom. Cord blood, a source of very "naive" blood stem cells, is used to treat some types of anaemia and leukaemia and may hold promise in treating other diseases.
The Human Tissue Authority announced this week that all maternity units, whether NHS or private, that collect cord blood must be operating under a licence by 5 July.
An unknown number of private companies are currently offering a cord blood collection service. They too will need a licence under the new regulations and must give an undertaking that cord blood will be collected by people with specialist training on premises that meet set standards. The authority estimates that between 100 and 250 public and private organisations will apply for a licence under the new rules.
Adrian
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+